| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 5 | |
| #2 | WIPO (World Intellectual Property Organization) | 5 | |
| #3 | Canada | 2 | |
| #4 | Australia | 1 | |
| #5 | Hong Kong | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement | |
| #4 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Measuring microorganism processes | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations | |
| #4 | Analysing materials | |
| #5 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Rosell Costa Rafael | 11 |
| #2 | Taron Roca Miguel | 11 |
| #3 | Molina Vila Miguel Ángel | 2 |
| #4 | Estrada Tejedor Roger | 2 |
| #5 | Puig De La Bellacasa Cazorla Raimon | 2 |
| #6 | Borrell Bilbao José Ignacio | 2 |
| #7 | Teixido Closa Jordi | 2 |
| #8 | García Román Silvia | 2 |
| #9 | Jimeno Doñaque José Mª | 1 |
| Publication | Filing date | Title |
|---|---|---|
| EP3120851A1 | 4-amino-6-(2,6-dichlorophenyl)-8-methyl-2-(phenylamino)-pyrido[2,3-d]pyrimidin-7(8h)-one for treatment of solid cancers | |
| WO2015058868A1 | Compositions and methods for the treatment of cancer | |
| WO2013190089A1 | Molecular biomarkers for predicting outcome in lung cancer | |
| EP2468883A1 | Molecular biomarkers for predicting response to tyrosine kinase inhibitors in lung cancer |